Home> Products> reabsorbing glucose back

{ "products": [ { "_id": "683d992c87328f4e892f8716", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EMPATECH 25", "description": "EMPATECH 25 is an advanced oral medication formulated with Empagliflozin 25 mg, a trusted and effective treatment for managing Type 2 Diabetes Mellitus (T2DM). It is part of a class of drugs known as SGLT2 inhibitors (sodium-glucose co-transporter 2 inhibitors), designed to help lower blood sugar levels in adults when used alongside proper diet and exercise. EMPATECH 25 not only improves glycemic control but also contributes to weight management and cardiovascular health in diabetic patients.\n\nKey Ingredients\nEmpagliflozin 25 mg: A selective SGLT2 inhibitor that helps remove excess glucose from the body through urine, lowering blood sugar levels in patients with type 2 diabetes.\n\nKey Benefits\nHelps significantly reduce elevated blood glucose (HbA1c) levels in Type 2 Diabetes\n\nSupports weight loss by reducing excess sugar stored in the body\n\nAids in lowering systolic blood pressure\n\nDemonstrated cardiovascular benefits, including reduced risk of heart failure hospitalization\n\nEnhances overall glycemic control without causing hypoglycemia when used alone\n\nConvenient once-daily oral dosing\n\nHow Does It Work?\nEmpagliflozin blocks the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose back into the bloodstream.\n\nBy inhibiting this protein, the medication increases glucose excretion through urine, thereby lowering blood sugar levels.\n\nIt works independently of insulin, making it a suitable option even when insulin resistance is present.\n\nAdditionally, this mechanism reduces blood pressure and body weight, offering multiple metabolic benefits beyond blood sugar control.\n\nDirections for Use\nTake one tablet of EMPATECH 25 orally once a day, preferably at the same time each day.\n\nIt can be taken with or without food.\n\nFollow the dosage as prescribed by your healthcare provider.\n\nDo not crush, chew, or break the tablet; swallow it whole with water.\n\nMaintain regular blood sugar monitoring and adhere to a balanced diet and exercise regimen.\n\nSide Effects\nIncreased urination\n\nGenital infections (e.g., yeast infections)\n\nUrinary tract infections (UTIs)\n\nThirst and mild dehydration\n\nLow blood pressure (especially in people on diuretics)\n\nDizziness or lightheadedness\n\nPossible increase in cholesterol levels\n\nIn rare cases, ketoacidosis (seek immediate medical attention if symptoms like nausea, vomiting, or abdominal pain occur)", "price": 225.0, "discountamount": 68.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "tablet swallow", "day preferably", "body aids", "nausea vomiting", "medical attention", "cholesterol levels", "diuretics dizziness", "crush chew", "healthcare provider", "food follow", "empatech 25 orally", "present additionally", "insulin resistance", "suitable option", "insulin making", "works independently", "sglt2 protein", "causing hypoglycemia", "reduced risk", "cardiovascular health", "weight management", "exercise empatech 25", "effective treatment", "empatech 25empatech 25", "balanced diet", "empagliflozin 25 mg", "glycemic control", "improves glycemic control", "work empagliflozin blocks", "selective sglt2 inhibitor", "alongside proper diet", "abdominal pain occur", "reabsorbing glucose back" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2130, "imageuri": "https://productimages.withfloats.com/actual/683d99313e1ed3094cddca21.png", "tileimageuri": "https://productimages.withfloats.com/tile/683d99313e1ed3094cddca21.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-06-02T12:29:32.123Z", "updatedon": "2025-06-02T12:31:28.199Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empatech-25/2130", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin 25 mg", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 25 mg", "empagliflozin 25 mg tablet", "Empagliflozin 25 mg brands in India", "Empagliflozin 25 mg Price in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66d8371d731125bdd4e105a4", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Canagliflozin 100mg", "description": "GLICANA FLOZIN 100\nCanagliflozin 100mg\nGLICANA FLOZIN 100 is a prescription medication formulated to manage blood sugar levels in individuals with type 2 diabetes. Containing 100mg of Canagliflozin, this medication belongs to the class of sodium-glucose co-transporter 2 (SGLT2) inhibitors. It works by helping the kidneys remove glucose from the bloodstream, thereby lowering blood sugar levels. GLICANA FLOZIN 100 is an effective option for patients who require additional glycemic control alongside diet and exercise.\n\n \n\nKey Benefits:\n \n\nEffective Glycemic Control: GLICANA FLOZIN 100 helps reduce blood sugar levels in individuals with type 2 diabetes, providing better overall glycemic management.\nCardiovascular Protection: Canagliflozin has been shown to reduce the risk of cardiovascular events in diabetic patients, offering a dual benefit of blood sugar control and heart health protection.\nWeight Management: By promoting glucose excretion, GLICANA FLOZIN 100 may also contribute to weight loss, which is beneficial for many diabetic patients.\nReduced Blood Pressure: The medication may help in lowering blood pressure, providing an additional health benefit for patients with hypertension.\n \n\nHow Does It Work?\n \n\nGLICANA FLOZIN 100 works by inhibiting the SGLT2 protein in the kidneys. This protein is responsible for reabsorbing glucose back into the bloodstream. By blocking its action, Canagliflozin prevents glucose reabsorption, leading to increased glucose excretion through urine. This process lowers blood sugar levels, helping to maintain optimal glycemic control in individuals with type 2 diabetes.\n\n \n\nDirections for Use:\n \n\nGLICANA FLOZIN 100 should be taken as prescribed by your healthcare provider. The typical dosage is one tablet per day, taken orally with or without food. It is important to follow the prescribed dosage and schedule strictly. Do not adjust the dose without consulting your doctor, and ensure regular monitoring of your blood sugar levels while on this medication.\n\n \n\nSide Effects:\n \n\nWhile GLICANA FLOZIN 100 is generally well-tolerated, some patients may experience side effects. Common side effects include urinary tract infections, increased urination, and thirst. In some cases, patients may experience dizziness, dehydration, or hypoglycemia. Serious side effects are rare but can include ketoacidosis, severe allergic reactions, or kidney problems. It is important to report any unusual symptoms to your healthcare provider promptly.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 660.0, "discountamount": 198.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "one tablet", "weight loss", "Key Benefits", "dual benefit", "transporter 2", "SGLT2 protein", "typical dosage", "GLICANA FLOZIN", "kidney problems", "type 2 diabetes", "unusual symptoms", "effective option", "glucose excretion", "SGLT2) inhibitors", "Weight Management", "regular monitoring", "blood sugar levels", "healthcare provider", "Common side effects", "blood sugar control", "glucose reabsorption", "Serious side effects", "cardiovascular events", "many diabetic patients", "Reduced Blood Pressure", "prescription medication", "heart health protection", "urinary tract infections", "optimal glycemic control", "Cardiovascular Protection", "additional health benefit", "severe allergic reactions", "Effective Glycemic Control", "overall glycemic management", "additional glycemic control" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1959, "imageuri": "https://productimages.withfloats.com/actual/66d8372188609327d5e09c08.png", "tileimageuri": "https://productimages.withfloats.com/tile/66d8372188609327d5e09c08.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-04T10:31:57.994Z", "updatedon": "2024-09-04T10:31:57.994Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/canagliflozin-100mg/1959", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLICANA FLOZIN 100", "category": "DIABETIC RANGE", "tags": [ "Canagliflozin 100mg uses", "Canagliflozin 100mg uses in hindi", "canagliflozin 100 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666159468da3a81d5c6a08d8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PAFAGOLD M 500 ", "description": "PAFAGOLD M 500 \nDapaflozin 10 mg + Metformin SR 500 mg\nIntroduction to PAFAGOLD M 500\nPAFAGOLD M 500 is a combination medication that includes Dapagliflozin 10mg and Metformin Hydrochloride Sustained Release (SR) 500mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Dapagliflozin and Metformin, PAFAGOLD M 500 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Dapagliflozin and Metformin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 (sodium-glucose co-transporter-2) inhibitor that works by preventing the kidneys from reabsorbing glucose back into the blood, which allows glucose to be excreted in the urine. This helps lower blood sugar levels. Dapagliflozin also offers additional benefits such as weight loss and cardiovascular protection.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nBenefits of PAFAGOLD M 500\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Dapagliflozin helps regulate fasting glucose levels by promoting glucose excretion through urine, while Metformin assists in lowering both fasting and postprandial (after-meal) glucose levels by promoting insulin sensitivity and reducing hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PAFAGOLD M 500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PAFAGOLD M 500 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nHow to Use PAFAGOLD M 500\nDosage and Administration\nRecommended Dosage: The typical dosage of PAFAGOLD M 500 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PAFAGOLD M 500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/pafagold-m-500-134322", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "Diet", "body", "Order", "liver", "EMAIL", "urine", "meals", "water", "action", "amount", "kidneys", "Support", "Overview", "readings", "calories", "biguanide", "one tablet", "full glass", "neuropathy", "Dapaflozin", "PAFAGOLD M", "Guidelines", "weight loss", "information", "Optimal Use", "Adjustments", "utilization", "retinopathy", "Introduction", "Reduced Risk", "Metformin SR", "best results", "sterisonline", "Postprandial", "sterispharma", "heart failure", "CALL/WHATSAPP", "effectiveness", "Consistent Use", "treatment plan", "sodium-glucose", "Administration", "dual mechanism", "typical dosage", "two medications", "prolonged effect", "Exercise Adjunct", "SGLT2 inhibitors", "excellent adjunct", "glucose excretion", "Weight Management", "diabetic patients", "multiple pathways", "glucose regulation", "Recommended Dosage", "Dapagliflozin 10mg", "additional benefits", "insulin sensitivity", "blood sugar control", "healthcare provider", "Diabetes Management", "individual response", "meal) glucose levels", "cardiovascular disease", "combination medication", "long-term complications", "lifestyle modifications", "Fasting Glucose Control", "cardiovascular benefits", "type 2 diabetes mellitus", "transporter-2) inhibitor", "complementary mechanisms", "cardiovascular protection", "peripheral glucose uptake", "stable blood sugar levels", "Additional Health Benefits", "hepatic glucose production", "gastrointestinal discomfort", "other cardiovascular events", "sustained-release formulation", "comprehensive glycemic control", "Effective Blood Sugar Management", "comprehensive blood sugar management", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1405, "imageuri": "https://productimages.withfloats.com/actual/666159486030c166b1a8a9f2.png", "tileimageuri": "https://productimages.withfloats.com/tile/666159486030c166b1a8a9f2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T06:37:58.426Z", "updatedon": "2024-06-29T10:36:59.351Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//pafagold-m-500-/1405", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PAFAGOLD M 500 ", "category": "DIABETIC RANGE", "tags": [ "PAFAGOLD M 500", "Dapaflozin 10 mg", "Metformin SR 500 mg", "Dapagliflozin 10 mg dosage", "Dapagliflozin 10 mg price", "Dapagliflozin 10 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6660561aea22b014e8af1a73", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PAFAGOLD M 1000 ", "description": "PAFAGOLD M 1000 \nDapagliflozin , Metformin Hydrochloride\nIntroduction to PAFAGOLD M 1000\nPAFAGOLD M 1000 is a combination medication that includes Dapagliflozin and Metformin Hydrochloride. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Dapagliflozin and Metformin, PAFAGOLD M 1000 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Dapagliflozin and Metformin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 (sodium-glucose co-transporter-2) inhibitor that works by preventing the kidneys from reabsorbing glucose back into the blood, which allows glucose to be excreted in the urine. This helps lower blood sugar levels. Dapagliflozin also offers additional benefits such as weight loss and cardiovascular protection.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization.\n\nBenefits of PAFAGOLD M 1000\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Dapagliflozin helps regulate fasting glucose levels by promoting glucose excretion through urine, while Metformin assists in lowering both fasting and postprandial (after-meal) glucose levels by promoting insulin sensitivity and reducing hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PAFAGOLD M 1000 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PAFAGOLD M 1000 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nHow to Use PAFAGOLD M 1000\nDosage and Administration\nRecommended Dosage: The typical dosage of PAFAGOLD M 1000 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PAFAGOLD M 1000 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/pafagold-m-1000-134127", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Diet", "body", "liver", "EMAIL", "urine", "Order", "meals", "water", "amount", "action", "kidneys", "Support", "Overview", "readings", "calories", "biguanide", "full glass", "Guidelines", "neuropathy", "PAFAGOLD M", "one tablet", "weight loss", "Optimal Use", "retinopathy", "information", "utilization", "Adjustments", "Introduction", "sterispharma", "best results", "Reduced Risk", "sterisonline", "Postprandial", "effectiveness", "heart failure", "CALL/WHATSAPP", "Dapagliflozin", "treatment plan", "Consistent Use", "sodium-glucose", "Administration", "dual mechanism", "typical dosage", "two medications", "SGLT2 inhibitors", "Exercise Adjunct", "multiple pathways", "excellent adjunct", "Weight Management", "diabetic patients", "glucose excretion", "Recommended Dosage", "glucose regulation", "Diabetes Management", "additional benefits", "blood sugar control", "insulin sensitivity", "healthcare provider", "individual response", "meal) glucose levels", "cardiovascular disease", "combination medication", "long-term complications", "lifestyle modifications", "cardiovascular benefits", "Fasting Glucose Control", "Metformin Hydrochloride", "type 2 diabetes mellitus", "transporter-2) inhibitor", "complementary mechanisms", "peripheral glucose uptake", "stable blood sugar levels", "cardiovascular protection", "hepatic glucose production", "Additional Health Benefits", "other cardiovascular events", "gastrointestinal discomfort", "comprehensive glycemic control", "Effective Blood Sugar Management", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1391, "imageuri": "https://productimages.withfloats.com/actual/6660561dc40ee9be0199735b.png", "tileimageuri": "https://productimages.withfloats.com/tile/6660561dc40ee9be0199735b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T12:12:10.69Z", "updatedon": "2024-06-29T11:03:11.406Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pafagold-m-1000-/1391", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PAFAGOLD M 1000 ", "category": "DIABETIC RANGE", "tags": [ "PAFAGOLD M 1000", "Dapagliflozin", "Metformin Hydrochloride", "Metformin hydrochloride uses", "Metformin hydrochloride side effects", "Metformin hydrochloride 1000 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666053368e599e12c0ea9a06", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PAFAGOLD 5 ", "description": "PAFAGOLD 5 \nDapagliflozin (5mg)\nIntroduction to PAFAGOLD 5\nPAFAGOLD 5 contains Dapagliflozin 5mg, a medication used primarily for the management of type 2 diabetes mellitus. Dapagliflozin belongs to a class of drugs known as SGLT2 (sodium-glucose co-transporter-2) inhibitors. It helps improve blood sugar control by preventing the kidneys from reabsorbing glucose back into the blood, allowing glucose to be excreted in the urine. This medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nWhat is Dapagliflozin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 inhibitor that works by blocking the reabsorption of glucose in the kidneys. This leads to the excretion of excess glucose through urine, thereby lowering blood sugar levels. Dapagliflozin also offers additional benefits such as weight loss and cardiovascular protection.\n\nMechanism of Action\nSGLT2 Inhibition: Dapagliflozin inhibits the SGLT2 protein in the kidneys, responsible for reabsorbing glucose back into the bloodstream. By blocking this protein, Dapagliflozin ensures that excess glucose is excreted in the urine.\nBlood Sugar Reduction: This mechanism helps lower blood sugar levels, particularly fasting blood glucose levels, contributing to overall glycemic control.\nBenefits of PAFAGOLD 5\nEffective Blood Sugar Management\nFasting Glucose Control: PAFAGOLD 5 helps lower fasting blood glucose levels by promoting the excretion of glucose through urine.\nComprehensive Glycemic Control: By targeting glucose reabsorption in the kidneys, Dapagliflozin provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PAFAGOLD 5 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PAFAGOLD 5 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nHow to Use PAFAGOLD 5\nDosage and Administration\nRecommended Dosage: The typical dosage of PAFAGOLD 5 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PAFAGOLD 5 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/pafagold-5-134125", "price": 120.0, "discountamount": 36.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "diet", "food", "drugs", "urine", "class", "EMAIL", "Order", "water", "adults", "Action", "kidneys", "Support", "calories", "PAFAGOLD", "readings", "Overview", "excretion", "same time", "Guidelines", "one tablet", "full glass", "neuropathy", "Consistency", "bloodstream", "Adjustments", "weight loss", "information", "retinopathy", "combination", "Optimal Use", "Introduction", "sterisonline", "best results", "sterispharma", "Reduced Risk", "heart failure", "SGLT2 protein", "CALL/WHATSAPP", "Administration", "sodium-glucose", "typical dosage", "treatment plan", "Consistent Use", "excess glucose", "SGLT2 inhibitor", "Exercise Adjunct", "SGLT2 Inhibition", "unique mechanism", "Dapagliflozin 5mg", "Weight Management", "diabetic patients", "excellent adjunct", "Recommended Dosage", "individual response", "healthcare provider", "blood sugar control", "Diabetes Management", "additional benefits", "glucose reabsorption", "blood glucose levels", "Blood Sugar Reduction", "cardiovascular disease", "cardiovascular benefits", "Fasting Glucose Control", "lifestyle modifications", "long-term complications", "type 2 diabetes mellitus", "overall glycemic control", "transporter-2) inhibitors", "cardiovascular protection", "stable blood sugar levels", "Additional Health Benefits", "other diabetes medications", "other cardiovascular events", "Comprehensive Glycemic Control", "Effective Blood Sugar Management", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1388, "imageuri": "https://productimages.withfloats.com/actual/666053389917812fea5771aa.png", "tileimageuri": "https://productimages.withfloats.com/tile/666053389917812fea5771aa.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:59:50.713Z", "updatedon": "2024-06-29T11:06:57.321Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pafagold-5-/1388", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PAFAGOLD 5 ", "category": "DIABETIC RANGE", "tags": [ "PAFAGOLD 5", "Dapagliflozin (5mg)", "Dapagliflozin 5 mg uses", "Dapagliflozin 5 mg price", "Dapagliflozin 5 mg dosage", "Dapagliflozin 5 mg substitute" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66605238a743fd235821fe26", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PAFAGOLD 10 ", "description": "PAFAGOLD 10 \nDapagliflozin (10mg)\nIntroduction to PAFAGOLD 10\nPAFAGOLD 10 contains Dapagliflozin 10mg, a medication primarily used for the management of type 2 diabetes mellitus. Dapagliflozin belongs to a class of drugs known as SGLT2 (sodium-glucose co-transporter-2) inhibitors. It helps improve blood sugar control by preventing the kidneys from reabsorbing glucose back into the blood, which allows glucose to be excreted in the urine. This medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nWhat is Dapagliflozin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 inhibitor that works by blocking the reabsorption of glucose in the kidneys. This leads to the excretion of excess glucose through urine, thereby lowering blood sugar levels. Dapagliflozin also offers additional benefits such as weight loss and cardiovascular protection.\n\nMechanism of Action\nSGLT2 Inhibition: Dapagliflozin inhibits the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose back into the bloodstream. By blocking this protein, Dapagliflozin ensures that excess glucose is excreted in the urine.\nBlood Sugar Reduction: This mechanism helps lower blood sugar levels, particularly fasting blood glucose levels, contributing to overall glycemic control.\nBenefits of PAFAGOLD 10\nEffective Blood Sugar Management\nFasting Glucose Control: PAFAGOLD 10 helps lower fasting blood glucose levels by promoting the excretion of glucose through urine.\nComprehensive Glycemic Control: By targeting glucose reabsorption in the kidneys, Dapagliflozin provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PAFAGOLD 10 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PAFAGOLD 10 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nHow to Use PAFAGOLD 10\nDosage and Administration\nRecommended Dosage: The typical dosage of PAFAGOLD 10 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PAFAGOLD 10 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/pafagold-10-134126", "price": 135.0, "discountamount": 40.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "diet", "food", "drugs", "urine", "class", "EMAIL", "Order", "water", "adults", "Action", "kidneys", "Support", "calories", "PAFAGOLD", "readings", "Overview", "excretion", "same time", "Guidelines", "one tablet", "full glass", "neuropathy", "Consistency", "bloodstream", "Adjustments", "weight loss", "information", "retinopathy", "combination", "Optimal Use", "Introduction", "sterisonline", "best results", "sterispharma", "Reduced Risk", "heart failure", "SGLT2 protein", "CALL/WHATSAPP", "Administration", "sodium-glucose", "typical dosage", "treatment plan", "Consistent Use", "excess glucose", "SGLT2 inhibitor", "Exercise Adjunct", "SGLT2 Inhibition", "unique mechanism", "Weight Management", "diabetic patients", "excellent adjunct", "Dapagliflozin 10mg", "Recommended Dosage", "individual response", "healthcare provider", "blood sugar control", "Diabetes Management", "additional benefits", "glucose reabsorption", "blood glucose levels", "Blood Sugar Reduction", "cardiovascular disease", "cardiovascular benefits", "Fasting Glucose Control", "lifestyle modifications", "long-term complications", "type 2 diabetes mellitus", "overall glycemic control", "transporter-2) inhibitors", "cardiovascular protection", "stable blood sugar levels", "Additional Health Benefits", "other diabetes medications", "other cardiovascular events", "Comprehensive Glycemic Control", "Effective Blood Sugar Management", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1386, "imageuri": "https://productimages.withfloats.com/actual/6660523bc06ee12d88ce1635.png", "tileimageuri": "https://productimages.withfloats.com/tile/6660523bc06ee12d88ce1635.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:55:36.543Z", "updatedon": "2024-06-29T11:14:01.571Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pafagold-10-/1386", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PAFAGOLD 10 ", "category": "DIABETIC RANGE", "tags": [ "PAFAGOLD 10", "Dapagliflozin (10mg)", "Dapagliflozin 10mg uses", "Dapagliflozin 10mg side effects", "Dapagliflozin 10 mg price", "Dapagliflozin 10 mg dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66604eb566170d1ff8cb2c6a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LINALIGLIP DAPA 5-10 ", "description": "LINALIGLIP DAPA 5-10 \nLinagliptin 5 mg & Dapagliflozin 10 mg\nIntroduction to LINALIGLIP DAPA 5-10\nLINALIGLIP DAPA 5-10 is a combination medication that includes Linagliptin 5mg and Dapagliflozin 10mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Linagliptin and Dapagliflozin, LINALIGLIP DAPA 5-10 provides comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Linagliptin and Dapagliflozin?\nOverview of Linagliptin\nLinagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that helps regulate blood glucose levels by increasing insulin release and decreasing glucagon levels in response to meals. By enhancing incretin hormones, Linagliptin aids in maintaining better overall blood sugar control throughout the day.\n\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 (sodium-glucose co-transporter-2) inhibitor that works by preventing the kidneys from reabsorbing glucose back into the blood. Instead, it allows glucose to be excreted in the urine, thereby lowering blood glucose levels. Dapagliflozin also offers additional benefits such as weight loss and cardiovascular protection.\n\nBenefits of LINALIGLIP DAPA 5-10\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Linagliptin helps regulate postprandial (after-meal) glucose levels, while Dapagliflozin assists in lowering fasting glucose levels by promoting glucose excretion through urine.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: LINALIGLIP DAPA 5-10 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, LINALIGLIP DAPA 5-10 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nHow to Use LINALIGLIP DAPA 5-10\nDosage and Administration\nRecommended Dosage: The typical dosage of LINALIGLIP DAPA 5-10 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow it whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take LINALIGLIP DAPA 5-10 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/linaliglip-dapa-5-10-134320", "price": 245.0, "discountamount": 73.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "food", "Diet", "Order", "urine", "EMAIL", "meals", "water", "action", "Support", "kidneys", "readings", "Overview", "calories", "same time", "full glass", "one tablet", "Guidelines", "neuropathy", "retinopathy", "Consistency", "Adjustments", "information", "Optimal Use", "weight loss", "best results", "Reduced Risk", "Postprandial", "sterispharma", "Introduction", "sterisonline", "Dapagliflozin", "heart failure", "CALL/WHATSAPP", "dual mechanism", "sodium-glucose", "typical dosage", "treatment plan", "Administration", "Consistent Use", "insulin release", "two medications", "Linagliptin 5mg", "LINALIGLIP DAPA", "glucagon levels", "linaliglip-dapa", "SGLT2 inhibitors", "Exercise Adjunct", "glucose excretion", "Weight Management", "diabetic patients", "excellent adjunct", "multiple pathways", "incretin hormones", "Recommended Dosage", "glucose regulation", "individual response", "Diabetes Management", "additional benefits", "healthcare provider", "meal) glucose levels", "blood glucose levels", "cardiovascular disease", "combination medication", "Fasting Glucose Control", "lifestyle modifications", "long-term complications", "cardiovascular benefits", "type 2 diabetes mellitus", "complementary mechanisms", "transporter-2) inhibitor", "cardiovascular protection", "stable blood sugar levels", "Additional Health Benefits", "other cardiovascular events", "overall blood sugar control", "comprehensive glycemic control", "Effective Blood Sugar Management", "dipeptidyl peptidase-4) inhibitor", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1380, "imageuri": "https://productimages.withfloats.com/actual/66604eb74f159c14e162af6b.png", "tileimageuri": "https://productimages.withfloats.com/tile/66604eb74f159c14e162af6b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:40:37.381Z", "updatedon": "2024-06-29T11:37:59.144Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/linaliglip-dapa-5-10-/1380", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGLIP DAPA 5-10 ", "category": "DIABETIC RANGE", "tags": [ "LINALIGLIP DAPA 5-10", "Linagliptin 5 mg", "Dapagliflozin 10 mg", "Dapagliflozin 10 mg dosage", "Dapagliflozin 10 mg price", "Dapagliflozin 10 mg Uses in Hindi", "Dapagliflozin 10 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666036ade5c8fb18fc193640", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPAFLOZIN M 5/500 ", "description": "GLIDAPAFLOZIN M 5/500 \nDapagliflozin (5mg), Metformin (500mg)\nIntroduction to GLIDAPAFLOZIN M 5/500\nGLIDAPAFLOZIN M 5/500 is a combination medication that includes Dapagliflozin 5mg and Metformin 500mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Dapagliflozin and Metformin, GLIDAPAFLOZIN M 5/500 provides comprehensive glycemic control, helping patients achieve better blood sugar management and overall metabolic health.\n\nWhat are Dapagliflozin and Metformin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 (sodium-glucose co-transporter-2) inhibitor that works by preventing the kidneys from reabsorbing glucose back into the blood. Instead, it allows glucose to be excreted in the urine, thereby lowering blood glucose levels.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization.\n\nBenefits of GLIDAPAFLOZIN M 5/500\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Dapagliflozin helps reduce both postprandial (after-meal) and fasting blood glucose levels by promoting glucose excretion through urine.\nBasal Glucose Control: Metformin helps maintain lower fasting blood sugar levels by improving insulin sensitivity and decreasing hepatic glucose production.\nWeight Management and Cardiovascular Benefits\nWeight Reduction: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nComprehensive Diabetes Management\nDual Mechanism: The combination of Dapagliflozin and Metformin offers a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nConvenience and Compliance: Combining two effective diabetes medications into one pill simplifies the treatment regimen, making it easier for patients to adhere to their prescribed therapy.\nHow to Use GLIDAPAFLOZIN M 5/500\nDosage and Administration\nRecommended Dosage: The typical dosage of GLIDAPAFLOZIN M 5/500 is one tablet taken twice daily, usually with meals. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take GLIDAPAFLOZIN M 5/500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-m-5-500-133424", "price": 128.79, "discountamount": 38.63, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "body", "meal", "risk", "water", "EMAIL", "liver", "Order", "urine", "amount", "action", "therapy", "kidneys", "readings", "one pill", "Overview", "calories", "Metformin", "biguanide", "full glass", "Guidelines", "one tablet", "Compliance", "utilization", "weight loss", "Adjustments", "information", "Optimal Use", "Convenience", "sterisonline", "Introduction", "sterispharma", "Postprandial", "best results", "heart failure", "effectiveness", "CALL/WHATSAPP", "Dapagliflozin", "Consistent Use", "sodium-glucose", "Dual Mechanism", "Administration", "typical dosage", "treatment plan", "GLIDAPAFLOZIN M", "SGLT2 inhibitors", "Weight Reduction", "Weight Management", "diabetic patients", "glucose excretion", "multiple pathways", "treatment regimen", "Recommended Dosage", "blood sugar levels", "glucose regulation", "insulin sensitivity", "individual response", "healthcare provider", "blood glucose levels", "Basal Glucose Control", "combination medication", "Fasting Glucose Control", "Cardiovascular Benefits", "transporter-2) inhibitor", "complementary mechanisms", "type 2 diabetes mellitus", "overall metabolic health", "Cardiovascular Protection", "peripheral glucose uptake", "hepatic glucose production", "gastrointestinal discomfort", "other cardiovascular events", "comprehensive glycemic control", "Effective Blood Sugar Management", "Comprehensive Diabetes Management", "two effective diabetes medications", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1359, "imageuri": "https://productimages.withfloats.com/actual/666036b0487c46164ce21532.png", "tileimageuri": "https://productimages.withfloats.com/tile/666036b0487c46164ce21532.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T09:58:05.188Z", "updatedon": "2024-06-29T12:36:58.891Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glidapaflozin-m-5-500-/1359", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN M 5/500 ", "category": "DIABETIC RANGE", "tags": [ "GLIDAPAFLOZIN M 5/500", "Dapagliflozin (5mg)", "Metformin (500mg)", "Dapagliflozin 5mg uses", "Dapagliflozin 5 mg uses", "Dapagliflozin 5 mg dosage", "Dapagliflozin 5 mg heart failure" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665efaa48ecffe165c350b61", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPA TENE 10/20 ", "description": "GLIDAPA TENE 10/20 \nDapagliflozin & Teneligliptin\nIntroduction\nGLIDAPA TENE 10/20 is a cutting-edge oral medication engineered for the management of Type 2 diabetes. This combination therapy includes Dapagliflozin (10 mg) and Teneligliptin (20 mg), two powerful drugs that work synergistically to control high blood sugar levels effectively.\n\nHow It Works\n\nDapagliflozin (10 mg): Dapagliflozin belongs to the class of drugs known as SGLT2 inhibitors. It works by preventing the kidneys from reabsorbing glucose back into the blood, promoting the excretion of glucose through urine. This leads to a reduction in blood glucose levels and can also aid in weight loss and blood pressure control.\nTeneligliptin (20 mg): Teneligliptin is a DPP-4 inhibitor that enhances the body's natural ability to lower blood sugar levels by increasing the release of insulin and decreasing the release of glucagon after meals. This helps to smooth out blood sugar spikes that can occur post-meal.\nBenefits\nGLIDAPA TENE 10/20 offers a comprehensive approach to diabetes management by targeting different pathways in glucose metabolism. The combination of Dapagliflozin and Teneligliptin provides a dual mechanism of action, which can be more effective in lowering blood glucose levels compared to monotherapy. This can also lead to improvements in HbA1c levels, a key indicator of long-term glycemic control.\n\nDosage and Administration\n\nDosage: The standard dosage is one tablet per day, but it should be adjusted based on the patient's specific medical condition, tolerance, and the effectiveness of the treatment.\nAdministration: GLIDAPA TENE 10/20 should be taken in the morning with or without food. Consistent daily intake helps maintain stable drug levels in the blood and ensures maximum efficacy.\nSide Effects\nThe most common side effects associated with GLIDAPA TENE 10/20 may include urinary tract infections due to the increased glucose in urine, and gastrointestinal disturbances such as nausea or constipation. Patients may also experience a slight risk of dehydration and should be advised to maintain adequate fluid intake.\n\nConclusion\nGLIDAPA TENE 10/20 is an innovative medication for managing Type 2 diabetes, providing potent dual-action control over high blood sugar levels. It simplifies the treatment regimen by combining two effective medications into a single daily dose, potentially enhancing patient compliance and improving overall diabetes management. As always, patients should consult their healthcare provider for personalized advice and to adjust the treatment plan as needed to achieve optimal health outcomes.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapa-tene-10-20-134223", "price": 255.0, "discountamount": 76.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "food", "meals", "urine", "Order", "class", "EMAIL", "nausea", "insulin", "morning", "release", "kidneys", "Patients", "glucagon", "Benefits", "excretion", "reduction", "tolerance", "Conclusion", "one tablet", "slight risk", "dehydration", "weight loss", "information", "monotherapy", "Introduction", "GLIDAPA TENE", "sterisonline", "HbA1c levels", "improvements", "constipation", "sterispharma", "effectiveness", "Dapagliflozin", "CALL/WHATSAPP", "key indicator", "dual mechanism", "treatment plan", "standard dosage", "Type 2 diabetes", "DPP-4 inhibitor", "natural ability", "maximum efficacy", "SGLT2 inhibitors", "single daily dose", "treatment regimen", "different pathways", "two powerful drugs", "glucose metabolism", "stable drug levels", "blood sugar spikes", "patient compliance", "personalized advice", "common side effects", "healthcare provider", "combination therapy", "blood glucose levels", "Teneligliptin (20 mg", "innovative medication", "Administration Dosage", "adequate fluid intake", "comprehensive approach", "blood pressure control", "optimal health outcomes", "high blood sugar levels", "Consistent daily intake", "urinary tract infections", "two effective medications", "specific medical condition", "long-term glycemic control", "potent dual-action control", "overall diabetes management", "gastrointestinal disturbances", "cutting-edge oral medication engineered" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1296, "imageuri": "https://productimages.withfloats.com/actual/665efaa8d93d0ca61a4976f3.png", "tileimageuri": "https://productimages.withfloats.com/tile/665efaa8d93d0ca61a4976f3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:29:40.684Z", "updatedon": "2024-06-04T11:29:40.684Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapa-tene-10-20-/1296", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPA TENE 10/20 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }